The company’s dedication to allocating a significant portion of its profits to cancer research through the Trust is deeply rooted in its history and personal loss. The Trust bears the name of Marion Gerauer, a native of Germany and one of the original founders, who succumbed to cancer at a young age. Her battle with cancer came as a total shock to her family, marking a period of profound tragedy. Despite the family’s efforts and substantial financial investment in treatments, they were confronted with the harsh reality that no available treatments could save her.
This personal tragedy illuminated a broader issue for the family: millions of people suffer from cancer, many of whom lack the resources to access proper treatment. Furthermore, it became apparent that innovative treatments, which could potentially save lives, were not accessible to everyone afflicted by this devastating disease.
Moved by the family’s tragedy and the widespread impact of cancer, the family was inspired to focus the Trust’s mission on funding cancer research and community development. This commitment aims not only to honor her memory but also to address the disparities in cancer treatment access and to foster the development of new, innovative treatments. Today, the Trust’s dedication to diverting profits towards cancer research stands as a testament to the company’s commitment to making a significant, positive impact on the health and well-being of communities worldwide, driven by the legacy of Marion Gerauer and the profound personal loss experienced by her family.